AUROPHARMA.NS
AUROPHARMA.NS
INE406A01037
AUROBINDO PHARMA LTD
Loading chart...

Company Profile

Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas. It also provides ointments, creams, gels, powders, transdermal, and lotions; antiretroviral drugs for PLHIV & CLHIV; and injectable products, including Penems, Penicillin, Cephalosporin, ophthalmic, inhalation, oncology, and hormone products. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Related stocks

CIPLA.NS
CIPLA.NS • India
CIPLA LTD
1,301 INR
10.86B USD 1Y -14%
LUPIN.NS
LUPIN.NS • India
LUPIN LIMITED
1,956.5 INR
9.24B USD 1Y -0.1%
RDY
RDY • India
Dr. Reddy's Laboratories Ltd
12.48 USD
10.4B USD 1Y -12.8%
DRREDDY.NS
DRREDDY.NS • India
DR. REDDY S LABORATORIES
1,197 INR
10.3B USD 1Y -3.9%
LAURUSLABS.NS
LAURUSLABS.NS • India
LAURUS LABS LIMITED
2,036.6 INR
11.37B USD 1Y +135.4%
ABBOTINDIA.NS
ABBOTINDIA.NS • India
ABBOTT INDIA LIMITED
26,000 INR
5.71B USD 1Y -14.5%
MANKIND.NS
MANKIND.NS • India
MANKIND PHARMA LIMITED
2,368.5 INR
10.11B USD 1Y -3.1%
ZYDUSLIFE.NS
ZYDUSLIFE.NS • India
ZYDUS LIFESCIENCES LTD
1,117.5 INR
11.52B USD 1Y +12.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
29.4% p.a.
Max Drawdown (5Y)
-45.2%
Sharpe Ratio (5Y)
0.55
Beta Factor
0.03
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (29.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -65.6% in the extended horizon.
ende